BRCA mutation carriers have little long-term survival benefit with ovarian cancer, researchers say
Sunday, February 17, 2013 - 16:30
in Health & Medicine
Researchers studied the long-term survival of women with a BRCA1 or BRCA2 gene mutation who were diagnosed with invasive ovarian cancer. They found that the short-term benefit to having either mutation does not lead to a long-term survival benefit.